SCHEMBL3479722

SCHEMBL3479722

CO[P](O)=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16638400 0.70
SCHEMBL126879 0.70
SCHEMBL9116304 0.67
SCHEMBL15908609 0.67
SCHEMBL65359 0.67
SCHEMBL18595034 0.67
Hydrochloric Acid SCHEMBL8993491 0.67
SCHEMBL6548869 0.67
Ammonia Solution, Strong SCHEMBL2743562 0.67
SCHEMBL11622956 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403329-B1 MIXING AND REACTING ALKYLOXY METHYLPHOSPHONIC ACID WITH DEHYDRATION AGENT TO MAKE CHOLINESTERASE INHIBITOR THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2002-06-11 US claimed
US-8889648-B2 Nucleic acid having an anti-metabolic syndrome effect NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2014-11-18 US disclosed
US-20130231383-A1 NUCLEIC ACID HAVING AN ANTI-METABOLIC SYNDROME EFFECT SHIONOGI & CO., LTD. (JP) 2013-09-05 US disclosed
EP-2619310-A2 A NUCLEIC ACID HAVING AN ANTI-METABOLIC SYNDROME EFFECT National University Corporation Hokkaido University (JP) 2013-07-31 EP disclosed
WO-2012039137-A2 A NUCLEIC ACID HAVING AN ANTI-METABOLIC SYNDROME EFFECT NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2012-03-29 WO disclosed
EP-2256215-A1 Assay system using a nuclease activity of a nucleic acid polymerase Mergemeier, Steffen (DE) 2010-12-01 EP disclosed
EP-1299408-A1 ACTIVE PROBE AND TARGET DETECTION Winger, Edward E. (US) 2003-04-09 EP disclosed
WO-2002000678-A1 ACTIVE PROBE AND TARGET DETECTION WINGER EDWARD E (US) 2002-01-03 WO disclosed
US-6262036-B1 CHIMERIC OLIGONUCLEOSIDE COMPOUNDS USEFUL IN ACTIVATING RNASEH-MEDIATED CLEAVAGE OF TARGET RIBONUCLEIC ACID SEQUENCES, AND IN TREATING DISEASE CONDITIONS RELATING TO SUCH SEQUENCES. GENTA INCORPORATED 2001-07-17 US disclosed
US-6251600-B1 AMPLIFICATION OF TARGET NUCLEOTIDE SEQUENCE; MIX NUCLEOTIDE SEQUENCES AND PROBES, INCUBATE WITH SPLITTING ENZYME, COUNT AND CLASSIFY THE AMOUNT OF PROBE RELEASE WINGER EDWARD E (US) 2001-06-26 US disclosed
US-6060456-A RNASE ACTIVATING REGION; GENETIC ENGINEERING; MOLECULAR HYBRIDIZATION GENTA INCORPORATED (US) 2000-05-09 US disclosed
US-5853990-A Real time homogeneous nucleotide assay Winger, Edward E. (US) 1998-12-29 US disclosed
US-5811538-A NORMAL PHASE COLUMN CHROMATOGRAPHY ON SUPPORT COMPRISING POLYHYDROXYETHYL ASPARTAMIDE, SILICA, HYDROPHILIC SILICA GENTA, INCORPORATED (US) 1998-09-22 US disclosed
WO-1998004738-A1 REAL TIME HOMOGENEOUS NUCLEOTIDE ASSAY WINGER EDWARD E (US) 1998-02-05 WO disclosed
EP-0743859-A1 CHIMERIC OLIGONUCLEOSIDE COMPOUNDS GENTA INCORPORATED (US) 1996-11-27 EP disclosed
WO-1995028942-A1 ANTISENSE OLIGOMERS FOR INHIBITING HUMAN PAPILLOMAVIRUSES GENTA INCORPORATED (US) 1995-11-02 WO disclosed
WO-1995018137-A1 IMPROVED PROCESS FOR THE PURIFICATION OF OLIGOMERS GENTA INCORPORATED (US) 1995-07-06 WO disclosed
US-5210015-A Polymerase chain reaction technique HOFFMAN-LA ROCHE INC. (US) 1993-05-11 US disclosed